Kazia Therapeutics KZIA
NASDAQ KZIA
$6.62 -0.33 (-4.75%)
At close: Nov 13, 2026 · 4:00 PM EST

Kazia Therapeutics (KZIA) Net Debt Issuances and Repayments (2024 - 2025)

Updated

Kazia Therapeutics (KZIA) reported Net Debt Issuances and Repayments of -$847,866 for FY2024 (year ended Dec 31, 2024), compared with -$29,907 in FY2023.

Analysis

Kazia Therapeutics (KZIA) Net Debt Issuances and Repayments (2024 - 2025) Analysis & Trends

Dating back to FY2013, Kazia Therapeutics' Net Debt Issuances and Repayments record includes 5 fiscal years.

  • The FY2024 figure ranks as the lowest annual Net Debt Issuances and Repayments in data going back to FY2013.
  • According to Business Quant data, Net Debt Issuances and Repayments came in at -$29,907 in FY2023 and $1.28 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Debt Issuance (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -5.28 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 2.28 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 9.48 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -682.00 Mn
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 4.91 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -3.05 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -19.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -87.00 Mn
10 Kazia Therapeutics 10.72 Mn -41.65 Mn - -194,893.29
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -194,893.29
Dec 31, 2024 -322,697.50
API Access

Kazia Therapeutics Net Debt Issuances and Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-debt-issuances-and-repayments&ticker=KZIA&period=max&api_key=YOUR_API_KEY